Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tian-Ren Zhou"'
Autor:
Hui-Yu Dong, Pan Zang, Mei-Ling Bao, Tian-Ren Zhou, Chen-Bo Ni, Lei Ding, Xu-Song Zhao, Jie Li, Chao Liang
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 6, Pp 687-694 (2023)
Recent studies revealed the relationship among homologous recombination repair (HRR), androgen receptor (AR), and poly(adenosine diphosphate-ribose) polymerase (PARP); however, the synergy between anti-androgen enzalutamide (ENZ) and PARP inhibitor o
Externí odkaz:
https://doaj.org/article/11f5a33e434640d8817bbd2a97da7930
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 3, Pp 287-295 (2023)
Most prostate cancers initially respond to androgen deprivation therapy (ADT). With the long-term application of ADT, localized prostate cancer will progress to castration-resistant prostate cancer (CRPC), metastatic CRPC (mCRPC), and neuroendocrine
Externí odkaz:
https://doaj.org/article/df5969fcb24947aab2c907643507e0d8
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 2, Pp 217-222 (2023)
The Prostate Imaging Reporting and Data System (PI-RADS) has good ability to identify the nature of lesions on prostate magnetic resonance imaging (MRI). However, some lesions are still reported as PI-RADS 4 and 5 but are biopsy-proven benign. Herein
Externí odkaz:
https://doaj.org/article/6fa29105c09643f59f1f8ef761a36f58
Publikováno v:
Asian Journal of Andrology. 25:217
Autor:
Lei Ding, Hui yu Dong, Tian ren Zhou, Yu hao Wang, Tao Yan, Jun chen Li, Zhong yuan Wang, Jie Li, Chao Liang
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6384-6401 (2021)
Abstract With the widespread use of PD‐1/PD‐L1 monoclonal antibodies (mAbs) in the treatment of multiple malignant tumors, they were also gradually applied to advanced renal cell carcinoma (aRCC). Nowadays, multiple PD‐1/PD‐L1 mAbs, such as n
Externí odkaz:
https://doaj.org/article/9eaeaf7fb09744d79cba180282df563a